Evidence map›Paper›PMID 30058478›Full record

ArticleEpigenetics2018

Analysis of KLF4 regulated genes in cancer cells reveals a role of DNA methylation in promoter- enhancer interactions.

Olutobi Oyinlade, Shuang Wei, Kai Kammers, Sheng Liu, Shuyan Wang, Ding Ma, Zhi-Yong Huang, Jiang Qian, Heng Zhu, Jun Wan and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Epigenetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Role of LMO7 in cancer (Review).Oncology reports · 2024
    Review
  3. Article
  4. Article
  5. KLF4 is an epigenetically modulated, context-dependent tumor suppressor.Frontiers in cell and developmental biology · 2024
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Whole-exome sequencing,American journal of cancer research · 2021
    Article
  11. Adenine DNA methylation, 3D genome organization, and gene expression in the parasiteProceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Olutobi Oyinladea Hugo W. Moser Research Institute at Kennedy Krieger , Baltimore , Maryland , USA.
Shuang Weia Hugo W. Moser Research Institute at Kennedy Krieger , Baltimore , Maryland , USA.
Kai Kammersd Division of Biostatistics and Bioinformatics,Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine , Johns Hopkins University , Baltimore , Maryland , USA.
Sheng Liui Department of Medical and Molecular Genetics , Indiana University School of Medicine , Indianapolis , IN , USA.
Shuyan Wanga Hugo W. Moser Research Institute at Kennedy Krieger , Baltimore , Maryland , USA.
Ding Maa Hugo W. Moser Research Institute at Kennedy Krieger , Baltimore , Maryland , USA.
Zhi-Yong Huangh Department of General Surgery, Tongji Hospital , Tongji Medical College Huazhong University of Science and Technology , Wuhan , China.
Jiang Qiane Wilmer Eye Institute,Johns Hopkins School of Medicine , Johns Hopkins University , Baltimore , Maryland , USA.
Heng Zhub Department of Pharmacology and Molecular Sciences , Johns Hopkins School of Medicine, Johns Hopkins University , Baltimore , Maryland , USA.
Jun Wani Department of Medical and Molecular Genetics , Indiana University School of Medicine , Indianapolis , IN , USA.
Shuli Xiaa Hugo W. Moser Research Institute at Kennedy Krieger , Baltimore , Maryland , USA.ORCID 0000-0001-5849-6967
Kennedy Krieger Institute · USJohns Hopkins University · USIndiana University School of MedicineTongji Hospital · CN

Funding

BIOCHEMISTRY, CELLULAR AND MOLECULAR BIOLOGY PROGRAMT32GM007445 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI GREEN, RACHEL · 1985 to 2021
$24.1M
Monospecific monoclonal antibodies against human transcription factorsU54HG006434 · NHGRI · JOHNS HOPKINS UNIVERSITY · PI BLACKSHAW, SETH, ZHU, HENG · 2011 to 2015
$13.8M
Proteome Characterization Center: A Genoproteomics Pipeline for Cance ResearchU24CA160036 · NCI · JOHNS HOPKINS UNIVERSITY · PI CHAN, DANIEL WANYUI, ZHANG, HUI · 2011 to 2016
$10.7M
Methyl-CpG-dependent transcription factor function in human gliomaR01NS091165 · NINDS · HUGO W. MOSER RES INST KENNEDY KRIEGER · PI XIA, SHULI · 2015 to 2019
$1.8M
Development of a virion display (VirD) array to profile human GPCR interactionsR33CA186790 · NCI · JOHNS HOPKINS UNIVERSITY · PI DESAI, PRASHANT J, ZHU, HENG · 2015 to 2017
$1.2M
NCI NIH HHS R33 CA186790NCI NIH HHS U24 CA160036NHGRI NIH HHS U54 HG006434NIGMS NIH HHS T32 GM007445NINDS NIH HHS R01 NS091165
6 · The paper itself

Abstract

Recent studies have revealed an unexpected role of DNA methylation at promoter regions in transcription activation. However, whether DNA methylation at enhancer regions activates gene expression and influences cellular functions remains to be determined. In this study, by employing the transcription factor krÜppel-like factor 4 (KLF4) that binds to methylated CpGs (mCpGs), we investigated the molecular outcomes of the recruitment of KLF4 to mCpGs at enhancer regions in human glioblastoma cells. First, by integrating KLF4 ChIP-seq, whole-genome bisulfite sequence, and H3K27ac ChIP-seq datasets, we found 1,299 highly methylated (β >0.5) KLF4 binding sites, three-quarters of which were located at putative enhancer regions, including gene bodies and intergenic regions. In the meantime, by proteomics, we identified 16 proteins as putative targets upregulated by KLF4-mCpG binding at enhancer regions. By chromosome conformation capture (3C) analysis, we demonstrated that KLF4 bound to methylated CpGs at the enhancer regions of the B-cell lymphocyte kinase (BLK) and Lim domain only protein 7 (LMO7) genes, and activated their expression via 3D chromatin loop formation with their promoter regions. Expression of mutant KLF4, which lacks KLF4 ability to bind methylated DNA, or removal of DNA methylation in enhancer regions by a DNA methyltransferase inhibitor abolished chromatin loop formation and gene expression, suggesting the essential role of DNA methylation in enhancer-promoter interactions. Finally, we performed functional assays and showed that BLK was involved in glioblastoma cell migration. Together, our study established the concept that DNA methylation at enhancer regions interacts with transcription factors to activate gene expression and influence cellular functions.

Indexed as

DNA MethylationEnhancer Elements, GeneticGene Expression Regulation, NeoplasticCell MovementCpG IslandsGlioblastomaHumansKruppel-Like Factor 4Kruppel-Like Transcription FactorsLIM Domain ProteinsPromoter Regions, Geneticsrc-Family KinasesTranscription FactorsTumor Cells, CulturedBLK protein, humanKLF4 protein, humanKruppel-Like Factor 4Kruppel-Like Transcription FactorsLIM Domain ProteinsLMO7 protein, humansrc-Family KinasesTranscription FactorsB-cell lymphocyte kinaseChromosome conformation captureenhancerKrÜppel-like factor 4 (KLF4)methylated DNA

Identifiers

PMID30058478
PMCPMC6224223
OpenAlexW2886713108

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.